LSTA (Lisata Therapeutics, Inc.) יחס שווי שוק לשווי בספרים
The historical price chart for Lisata Therapeutics (LSTA) reflects the price action of a non-cyclical drug delivery systems developer whose success is driven by the progress of clinical trials, with the metric standing at 1.13. The business relies on precision component logistics to preserve therapeutic properties. Lisata Therapeutics (LSTA) is currently scaling its platform, aiming to advance its lead candidate to the final stages of testing and attract strategic partners.
פילוחי מדדים פיננסיים ומדדי שוק עבור Lisata Therapeutics (LSTA)
High R&D expenditures in oncology at Lisata Therapeutics (LSTA) are creating significant pressure on the company's liquidity. This metric is calculated as the quotient of the total market capitalization divided by the amount of shareholders' equity. This indicator measures the extent of the premium or discount of the market valuation relative to book assets. High values signal leadership but increase vulnerability to fiscal changes. Analyze the market-to-book ratio to compare current quotes with the historical trend.